Page last updated: 2024-08-23

tetradecanoylphorbol acetate and calcipotriene

tetradecanoylphorbol acetate has been researched along with calcipotriene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Iwatsuki, K; Kaneko, F; Maruyama, K; Ono, I; Zhang, JZ1
Keski-Oja, J; Koli, K1
Bian, L; Chu, Z; Gu, Y; Guo, J; He, G; Li, J; Lin, G; Ma, X; Mo, J; Shao, L; Xu, Q; Xu, Y; Ye, W; Zhao, Y; Zhu, Q1

Other Studies

3 other study(ies) available for tetradecanoylphorbol acetate and calcipotriene

ArticleYear
Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1 alpha) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1).
    Journal of dermatological science, 1994, Volume: 7, Issue:1

    Topics: Calcitriol; Carcinoma, Squamous Cell; Cholecalciferol; Dermatologic Agents; Humans; Interleukin-1; Interleukin-8; Keratinocytes; Reference Values; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1994
Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
    The Journal of investigative dermatology, 1993, Volume: 101, Issue:5

    Topics: Animals; Calcitriol; Cells, Cultured; Cholecalciferol; Dermatologic Agents; Extracellular Matrix; Humans; Keratinocytes; Mice; Mice, Inbred BALB C; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Protein Biosynthesis; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator

1993
Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.
    European journal of medicinal chemistry, 2021, Mar-05, Volume: 213

    Topics: Animals; Boron Compounds; Calcitriol; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Guinea Pigs; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Molecular Structure; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tetradecanoylphorbol Acetate

2021